Antiangiogenics: The potential role of integrating this novel treatment modality with chemoradiation for solid cancers

被引:101
作者
Duda, Dan G.
Jain, Rakesh K.
Willett, Christopher G.
机构
[1] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC 27710 USA
[2] Massachusetts Gen Hosp, Dept Radiat Oncol, Steele Lab Tumor Biol, Boston, MA 02114 USA
关键词
D O I
10.1200/JCO.2007.11.3985
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although still in very early stages of clinical development, the combination of antiangiogenics with contemporary chemoradiotherapy regimens has emerged as a feasible and promising approach to many cancers. We review the rationale and the current understanding of antiangiogenics and their therapeutic potential in combination with chemoradiotherapy. Finally, we offer a perspective on future research directions aimed at making this complex therapeutic approach successful in the clinic.
引用
收藏
页码:4033 / 4042
页数:10
相关论文
共 65 条
[1]  
Ansiaux R, 2005, CLIN CANCER RES, V11, P743
[2]   AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients [J].
Batchelor, Tracy T. ;
Sorensen, A. Gregory ;
di Tomaso, Emmanuelle ;
Zhang, Wei-Ting ;
Duda, Dan G. ;
Cohen, Kenneth S. ;
Kozak, Kevin R. ;
Cahill, Daniel P. ;
Chen, Poe-Jou ;
Zhu, Mingwang ;
Ancukiewicz, Marek ;
Mrugala, Maciej M. ;
Plotkin, Scott ;
Drappatz, Jan ;
Louis, David N. ;
Ivy, Percy ;
Scadden, David T. ;
Benner, Thomas ;
Loeffler, Jay S. ;
Wen, Patrick Y. ;
Jain, Rakesh K. .
CANCER CELL, 2007, 11 (01) :83-95
[3]   Glioblastoma cells block radiation-induced programmed cell death of endothelial cells [J].
Brown, CK ;
Khodarev, NN ;
Yu, JQ ;
Moo-Young, T ;
Labay, E ;
Darga, TE ;
Posner, MC ;
Weichselbaum, RR ;
Mauceri, HJ .
FEBS LETTERS, 2004, 565 (1-3) :167-170
[4]   Angiogenesis in cancer and other diseases [J].
Carmeliet, P ;
Jain, RK .
NATURE, 2000, 407 (6801) :249-257
[5]   Urinary VEGF and MMP levels as predictive markers of 1-year progression-free survival in cancer patients treated with radiation therapy:: A longitudinal study of protein kinetics throughout tumor progression and therapy [J].
Chan, LW ;
Moses, MA ;
Goley, E ;
Sproull, M ;
Muanza, T ;
Coleman, CN ;
Figg, WD ;
Albert, PS ;
Ménard, C ;
Camphausen, K .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (03) :499-506
[6]   Phase II study of temozolomide and thalidomide with radiation therapy for newly diagnosed glioblastoma multiforme [J].
Chang, SM ;
Lamborn, KR ;
Malec, M ;
Larson, D ;
Wara, W ;
Sneed, P ;
Rabbitt, J ;
Page, M ;
Nicholas, MK ;
Prados, MD .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (02) :353-357
[7]   Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer [J].
Crane, CH ;
Ellis, LM ;
Abbruzzese, JL ;
Amos, C ;
Xiong, HQ ;
Ho, L ;
Evans, DB ;
Tamm, EP ;
Ng, C ;
Pisters, PWT ;
Charnsangavej, C ;
Delclos, ME ;
O'Reilly, M ;
Lee, JE ;
Wolff, R .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (07) :1145-1151
[8]   Bevacizumab, oxaliplatin, and capecitabine with radiation therapy in rectal cancer: Phase I trial results [J].
Czito, Brian G. ;
Bendell, Johanna C. ;
Willett, Christopher G. ;
Morse, Michael A. ;
Blobe, Gerard C. ;
Tyler, Douglas S. ;
Thomas, John ;
Ludwig, Kirk A. ;
Mantyh, Christopher R. ;
Ashton, Jill ;
Yu, Daohai ;
Hurwitz, Herbert I. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 68 (02) :472-478
[9]   Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial [J].
Demetri, George D. ;
van Oosterom, Allan T. ;
Garrett, Christopher R. ;
Blackstein, Martin E. ;
Shah, Manisha H. ;
Verweij, Jaap ;
McArthur, Grant ;
Judson, Ian R. ;
Heinrich, Michael C. ;
Morgan, Jeffrey A. ;
Desai, Jayesh ;
D Fletcher, Christopher ;
George, Suzanne ;
Bello, Carlo L. ;
Huang, Xin ;
Baum, Charles M. ;
Casali, Paolo G. .
LANCET, 2006, 368 (9544) :1329-1338
[10]  
Dowlati A, 2006, J CLIN ONCOL, V24, p370S